1. Lindsay S. Carcinoma of the thyroid gland: a clinical and pathologic study of 293 patients at the university of California hospital. Springfield Ill: Charles C Thomas; 1960. [Google Scholar]
2. Chen KT, Rosai J. Follicular variant of thyroid papillary carcinoma: a clinicopathologic study of six cases. Am J Surg Pathol. 1977;1(2):123–130. [PubMed] [Google Scholar]
3. LiVolsi VA, Asa SL. The demise of follicular carcinoma of the thyroid gland. Thyroid. 1994;4(2):233–236. [PubMed] [Google Scholar]
4. Tallini G, Tuttle RM, Ghossein RA. The history of the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab. 2016 doi:10.1210/jc.2016-2976. [PubMed] [CrossRef] [Google Scholar]
5. Thompson LD. Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: a name change to noninvasive follicular thyroid neoplasm with papillary-like nuclear features would help prevent overtreatment. Mod Pathol. 2016;29(7):698–707. [PubMed] [Google Scholar]
6. Zhu Z, Gandhi M, Nikiforova MN, Fischer AH, Nikiforov YE. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations. Am J Clin Pathol. 2003;120(1):71–77. [PubMed] [Google Scholar]
7. Wreesmann VB, Ghossein RA, Hezel M, Banerjee D, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B. Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity. Genes Chromosomes Cancer. 2004;40(4):355–364. [PubMed] [Google Scholar]
8. Giordano TJ, Kuick R, Thomas DG, Misek DE, Vinco M, Sanders D, Zhu Z, Ciampi R, Roh M, Shedden K, et al. Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis. Oncogene. 2005;24(44):6646–6656. [PubMed] [Google Scholar]
9. Rivera M, Ricarte-Filho J, Knauf J, Shaha A, Tuttle M, fa*gin JA, Ghossein RA. Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns. Mod Pathol. 2010;23(9):1191–1200. [PMC free article] [PubMed] [Google Scholar]
10. Howitt BE, Jia Y, Sholl LM, Barletta JA. Molecular alterations in partially-encapsulated or well-circ*mscribed follicular variant of papillary thyroid carcinoma. Thyroid. 2013;23(10):1256–1262. [PubMed] [Google Scholar]
11. Cancer Genome Atlas Research N Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014;159(3):676–690. [PMC free article] [PubMed] [Google Scholar]
12. Liu J, Singh B, Tallini G, Carlson DL, Katabi N, Shaha A, Tuttle RM, Ghossein RA. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer. 2006;107(6):1255–1264. [PubMed] [Google Scholar]
13. Widder S, Guggisberg K, Khalil M, Pasieka JL. A pathologic re-review of follicular thyroid neoplasms: the impact of changing the threshold for the diagnosis of the follicular variant of papillary thyroid carcinoma. Surgery. 2008;144(1):80–85. [PubMed] [Google Scholar]
14. Piana S, Frasoldati A, Di Felice E, Gardini G, Tallini G, Rosai J. Encapsulated well-differentiated follicular-patterned thyroid carcinomas do not play a significant role in the fatality rates from thyroid carcinoma. Am J Surg Pathol. 2010;34(6):868–872. [PubMed] [Google Scholar]
15. Vivero M, Kraft S, Barletta JA. Risk stratification of follicular variant of papillary thyroid carcinoma. Thyroid. 2013;23(3):273–279. [PubMed] [Google Scholar]
16. Ganly I, Wang L, Tuttle RM, Katabi N, Ceballos GA, Harach HR, Ghossein R. Invasion rather than nuclear features correlates with outcome in encapsulated follicular tumors: further evidence for the reclassification of the encapsulated papillary thyroid carcinoma follicular variant. Hum Pathol. 2015;46(5):657–664. [PMC free article] [PubMed] [Google Scholar]
17. Rosario PW, Penna GC, Calsolari MR. Noninvasive encapsulated follicular variant of papillary thyroid carcinoma: is lobectomy sufficient for tumours %3e/=1 cm? Clin Endocrinol (Oxf) 2014;81(4):630–632. [PubMed] [Google Scholar]
18. Rivera M, Tuttle RM, Patel S, Shaha A, Shah JP, Ghossein RA. Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern) Thyroid. 2009;19(2):119–127. [PubMed] [Google Scholar]
19. Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LD, Barletta JA, Wenig BM, Al Ghuzlan A, Kakudo K, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2016;2(8):1023–1029. [PMC free article] [PubMed] [Google Scholar]
20. Haugen BR, Sawka AM, Alexander EK, Bible KC, Caturegli P, Doherty GM, Mandel SJ, Morris JC, Nassar A, Pacini F, et al. American thyroid association guidelines on the management of thyroid nodules and differentiated thyroid cancer task force review and recommendation on the proposed renaming of encapsulated follicular variant papillary thyroid carcinoma without invasion to noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Thyroid. 2017;27(4):481–483. [PubMed] [Google Scholar]
21. NCCN clinical practive guidelines in oncology (NCCN guidelines): thyroid carcinoma. Version 1.2019 https://www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf
22. Ferris RL, Nikiforov Y, Terris D, Seethala RR, Ridge JA, Angelos P, Duh QY, Wong R, Sabra MM, fa*gin JA, et al. AHNS Series: Do you know your guidelines? AHNS endocrine section consensus statement: state-of-the-art thyroid surgical recommendations in the era of noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Head Neck. 2018;40(9):1881–1888. [PMC free article] [PubMed] [Google Scholar]
23. Xu B, Reznik E, Tuttle RM, Knauf J, fa*gin JA, Katabi N, Dogan S, Aleynick N, Seshan V, Middha S, et al. Outcome and molecular characteristics of non-invasive encapsulated follicular variant of papillary thyroid carcinoma with oncocytic features. Endocrine. 2019;64(1):97–108. [PMC free article] [PubMed] [Google Scholar]
24. Xu B, Farhat N, Barletta JA, Hung YP, Biase D, Casadei GP, Onenerk AM, Tuttle RM, Roman BR, Katabi N, et al. Should subcentimeter non-invasive encapsulated, follicular variant of papillary thyroid carcinoma be included in the noninvasive follicular thyroid neoplasm with papillary-like nuclear features category? Endocrine. 2018;59(1):143–150. [PMC free article] [PubMed] [Google Scholar]
25. Xu B, Tallini G, Scognamiglio T, Roman BR, Tuttle RM, Ghossein RA. Outcome of large noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Thyroid. 2017;27(4):512–517. [PMC free article] [PubMed] [Google Scholar]
26. Mariani RA, Kadakia R, Arva NC. Noninvasive encapsulated follicular variant of papillary thyroid carcinoma: should it also be reclassified in children? Pediatr Blood Cancer. 2018;65(6):e26966. [PubMed] [Google Scholar]
27. Johnson DN, Furtado LV, Long BC, Zhen CJ, Wurst M, Mujacic I, Kadri S, Segal JP, Antic T, Cipriani NA. Noninvasive follicular thyroid neoplasms with papillary-like nuclear features are genetically and biologically similar to adenomatous nodules and distinct from papillary thyroid carcinomas with extensive follicular growth. Arch Pathol Lab Med. 2018;142(7):838–850. [PubMed] [Google Scholar]
28. Shafique K, LiVolsi VA, Montone K, Baloch ZW. Papillary thyroid microcarcinoma: reclassification to non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): a retrospective clinicopathologic study. Endocr Pathol. 2018;29(4):339–345. [PubMed] [Google Scholar]
29. Kim MJ, Won JK, Jung KC, Kim JH, Cho SW, Park DJ, Park YJ. Clinical characteristics of subtypes of follicular variant papillary thyroid carcinoma. Thyroid. 2018;28(3):311–318. [PubMed] [Google Scholar]
30. Parente DN, Kluijfhout WP, Bongers PJ, Verzijl R, Devon KM, Rotstein LE, Goldstein DP, Asa SL, Mete O, Pasternak JD. Clinical safety of renaming encapsulated follicular variant of papillary thyroid carcinoma: is NIFTP truly benign? World J Surg. 2018;42(2):321–326. [PubMed] [Google Scholar]
31. Cho U, Mete O, Kim MH, Bae JS, Jung CK. Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular variant papillary thyroid carcinoma: the impact of rigid criteria to distinguish non-invasive follicular thyroid neoplasm with papillary-like nuclear features. Mod Pathol. 2017;30(6):810–825. [PubMed] [Google Scholar]
32. Gao X, Zhang X, Zhang Y, Hua W, Maimaiti Y, Gao Z. Is papillary thyroid microcarcinoma an indolent tumor?: a retrospective study on 280 cases treated with radioiodine. Medicine (Baltimore) 2016;95(40):e5067. [PMC free article] [PubMed] [Google Scholar]
33. Mehanna H, Al-Maqbili T, Carter B, Martin E, Campain N, Watkinson J, McCabe C, Boelaert K, Franklyn JA. Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma: a systematic review and meta-analysis of 21 329 person-years of follow-up. J Clin Endocr Metab. 2014;99(8):2834–2843. [PubMed] [Google Scholar]
34. Piana S, Ragazzi M, Tallini G, de Biase D, Ciarrocchi A, Frasoldati A, Rosai J. Papillary thyroid microcarcinoma with fatal outcome: evidence of tumor progression in lymph node metastases: report of 3 cases, with morphological and molecular analysis. Hum Pathol. 2013;44(4):556–565. [PubMed] [Google Scholar]
35. Tallini G, de Biase D, Durante C, Acquaviva G, Bisceglia M, Bruno R, Bacchi Reggiani ML, Casadei GP, Costante G, Cremonini N, et al. BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study. Mod Pathol. 2015;28(10):1343–1359. [PubMed] [Google Scholar]
36. Xu B, Scognamiglio T, Cohen PR, Prasad ML, Hasanovic A, Tuttle RM, Katabi N, Ghossein RA. Metastatic thyroid carcinoma without identifiable primary tumor within the thyroid gland: a retrospective study of a rare phenomenon. Hum Pathol. 2017;65:133–139. [PMC free article] [PubMed] [Google Scholar]
37. Nishikawa M, Toyoda N, Yonemoto T, Fujiyama A, Ogawa Y, Tokoro T, Sakaguchi N, Yoshimura M, Yoshikawa N, Tabata S, et al. Occult papillary thyroid carcinoma in Hashimoto's thyroiditis presenting as a metastatic bone tumor. Endocr J. 1998;45(1):111–116. [PubMed] [Google Scholar]
38. Lloyd RV, Asa SL, LiVolsi VA, Sadow PM, Tischler AS, Ghossein RA, Tuttle RM, Nikiforov YE. The evolving diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) Hum Pathol. 2018;74:1–4. [PubMed] [Google Scholar]
39. Nikiforov YE, Baloch ZW, Hodak SP, Giordano TJ, Lloyd RV, Seethala RR, Wenig BM. Change in diagnostic criteria for noninvasive follicular thyroid neoplasm with papillarylike nuclear features. JAMA Oncol. 2018;4(8):1125–1126. [PMC free article] [PubMed] [Google Scholar]
40. Xu B, Serrette R, Tuttle RM, Alzumaili B, Ganly I, Katabi N, Tallini G, Ghossein R. How Many papillae in conventional papillary carcinoma? a clinical evidence-based pathology study of 235 unifocal encapsulated papillary thyroid carcinomas, with emphasis on the diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features. Thyroid. 2019;29(12):1792. [PMC free article] [PubMed] [Google Scholar]
41. Amin MB, Edge SB, Greene FL, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Madera M, et al. AJCC cancer staging manual. 8. New York: Springer Nature; 2017. [Google Scholar]
42. Canberk S, Montezuma D, Tastekin E, Grangeia D, Demirhas MP, Akbas M, Tokat F, Ince U, Soares P, Schmitt F. The other side of the coin": understanding noninvasive follicular tumor with papillary-like nuclear features in unifocal and multifocal settings. Hum Pathol. 2019;86:136–142. [PubMed] [Google Scholar]
43. Steward DL, Carty SE, Sippel RS, Yang SP, Sosa JA, Sipos JA, Figge JJ, Mandel S, Haugen BR, Burman KD, et al. Performance of a multigene genomic classifier in thyroid nodules with indeterminate cytology: a prospective blinded multicenter study. JAMA Oncol. 2018 doi:10.1001/jamaoncol.2018.4616. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
44. Zhang M, Lin O. Molecular testing of thyroid nodules: a review of current available tests for fine-needle aspiration specimens. Arch Pathol Lab Med. 2016;140(12):1338–1344. [PubMed] [Google Scholar]
45. Ferris RL, Baloch Z, Bernet V, Chen A, Fahey TJ, 3rd, Ganly I, Hodak SP, Kebebew E, Patel KN, Shaha A, et al. American thyroid association statement on surgical application of molecular profiling for thyroid nodules: current impact on perioperative decision making. Thyroid. 2015;25(7):760–768. [PMC free article] [PubMed] [Google Scholar]
46. Rossi ED, Larocca LM, Pantanowitz L. Ancillary molecular testing of indeterminate thyroid nodules. Cancer Cytopathol. 2018;126(Suppl 8):654–671. [PubMed] [Google Scholar]
47. Alexander EK, Kennedy GC, Baloch ZW, Cibas ES, Chudova D, Diggans J, Friedman L, Kloos RT, LiVolsi VA, Mandel SJ, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med. 2012;367(8):705–715. [PubMed] [Google Scholar]
48. Hang JF, Westra WH, Zhou AG, Cooper DS, Ali SZ. The impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on the rate of malignancy for atypia of undetermined significance subcategories. Cancer Cytopathol. 2018;126(5):309–316. [PubMed] [Google Scholar]
49. Jug RC, Datto MB, Jiang XS. Molecular testing for indeterminate thyroid nodules: performance of the Afirma gene expression classifier and ThyroSeq panel. Cancer Cytopathol. 2018;126(7):471–480. [PubMed] [Google Scholar]
50. Johnson DN, Sadow PM. Exploration of BRAFV600E as a diagnostic adjuvant in the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) Hum Pathol. 2018;82:32. [PubMed] [Google Scholar]
51. Zhao L, Dias-Santagata D, Sadow PM, Faquin WC. Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma. Cancer. 2017;125(5):323. [PubMed] [Google Scholar]
52. Brandler TC, Liu CZ, Cho M, Zhou F, Cangiarella J, Yee-Chang M, Shi Y, Simsir A, Sun W. Does noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) have a unique molecular profile? Am J Clin Pathol. 2018;150(5):451–460. [PubMed] [Google Scholar]
53. Basolo F, Macerola E, Ugolini C, Poller DN, Baloch Z. The molecular landscape of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): a literature review. Adv Anat Pathol. 2017;24(5):252–258. [PubMed] [Google Scholar]
